These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2511743)

  • 1. Usefulness of sustained-release diltiazem for stable angina pectoris.
    Klinke WP; Juneau M; Grace M; Kostuk WJ; Pflugfelder P; Maranda CR; Warnica W; Chin C; Annable L; Dempsey EE
    Am J Cardiol; 1989 Dec; 64(19):1249-52. PubMed ID: 2511743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excessive reduction in peripheral resistance during exercise and risk of orthostatic symptoms with sustained-release nitroglycerin and diltiazem treatment of angina.
    Bruce RA; Hossack KF; Kusumi F; Day B; Kannagi T
    Am Heart J; 1985 May; 109(5 Pt 1):1020-6. PubMed ID: 3922207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
    Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
    Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
    Glasser SP; Gana TJ; Pascual LG; Albert KS
    Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of sustained-release diltiazem in stable angina pectoris.
    Weiner DA; Cutler SS; Klein MD
    Am J Cardiol; 1986 Jan; 57(1):6-9. PubMed ID: 3510525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
    Boden WE; Bough EW; Reichman MJ; Rich VB; Young PM; Korr KS; Shulman RS
    Circulation; 1985 Jun; 71(6):1197-205. PubMed ID: 2859931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diltiazem dose responses in sustained therapy for stable angina pectoris.
    McCans JL
    Can J Cardiol; 1986; 2(6):332-7. PubMed ID: 3100007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris.
    Vliegen HW; van der Wall EE; Niemeyer MG; Holwerda NJ; Bernink PJ; de Weerd P; Bosma AH; van der Wieken LR; Timmermans AJ; Molhoek GP
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S55-60. PubMed ID: 1725545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of diltiazem standard formulation and diltiazem controlled release in patients with stable angina pectoris: a randomized, double-blind, cross-over, multicenter study.
    Vliegen HW; van der Wall EE; Kragten JA; Holwerda NJ; Schenkel WM; Muijs van de Moer WM; ten Kate JB; Mulder PG; Bruschke AV
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):552-9. PubMed ID: 7681899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of once-daily diltiazem in patients with stable angina pectoris switched from twice-daily diltiazem.
    Savard D; Lenis J; Juneau M; Jacob C; Boulet AP
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):85-9. PubMed ID: 7564371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four hour efficacy of two dose levels of a once daily sustained-release diltiazem formulation in stable angina: a placebo-controlled trial. The Dildurang Study Group.
    Frances Y; Gagey S; Stalla-Bourdillon A
    Br J Clin Pharmacol; 1995 Mar; 39(3):277-82. PubMed ID: 7619669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of high-dose diltiazem for chronic stable angina pectoris: 16-month serial studies with placebo controls.
    Petru MA; Crawford MH; Kennedy GT; Amon KW; O'Rourke RA
    Am Heart J; 1985 Jan; 109(1):99-103. PubMed ID: 3880993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris.
    De Rosa ML; Giordano A; Melfi M; Della Guardia D; Ciaburri F; Rengo F
    Int J Cardiol; 1998 Jan; 63(1):27-35. PubMed ID: 9482142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled trial of sustained-release diltiazem in patients with angina. Sustained-Release Diltiazem Study Group.
    Weiss RJ; Hicks D; Bittar N; Bowers J; Shah A
    Clin Ther; 1993; 15(6):1069-75. PubMed ID: 8111804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris.
    Emanuelsson H; Ake H; Kristi M; Arina R
    Eur J Clin Pharmacol; 1989; 36(6):561-6. PubMed ID: 2506059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antianginal efficacy and safety of controlled-delivery diltiazem QD versus an equivalent dose of immediate-release diltiazem TID.
    Klinke WP; Baird M; Juneau M; Waters D; Warnica W; Lakhani Z; Annable L; Boulet AP; Larivière L
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):319-30. PubMed ID: 7662599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group.
    Thadani U; Glasser S; Bittar N; Beach CL
    Am J Cardiol; 1994 Jul; 74(1):9-17. PubMed ID: 8017316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term antianginal and antiischemic effects of mibefradil, the novel T-type calcium channel blocker: a multicenter, double-blind, placebo-controlled, randomized comparison with sustained-release diltiazem.
    Davies GJ; Kobrin I; Caspi A; Reisin LH; de Albuquerque DC; Armagnijan D; Coelho OR; Schneeweiss A
    Am Heart J; 1997 Aug; 134(2 Pt 1):220-8. PubMed ID: 9313601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind comparison of the efficacy and tolerability of once-daily modified-release diltiazem capsules with once-daily amlodipine tablets in patients with stable angina.
    Chugh SK; Digpal K; Hutchinson T; McDonald CJ; Miller AJ; Lahiri A
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):356-64. PubMed ID: 11486240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.